EU Healthcare Sector Specialist Commentary

Research evidence excerpt

EU Healthcare Sector Specialist Commentary

Marjan Daeipour - Specialist Sales - European Healthcare AC (44 20) 7134-1329 Europe Specialist Sales J P M O R G A N

marjan.daeipour@jpmorgan.com JPM | MD's Daily Meds:Elekta

J.P. Morgan Securities plc 18 June 2026

Event Type Start Date Event Name

Corporate Access June 18, 2026 J P Morgan European Healthcare Conference, London

Analyst Access June 29, 2026 Richard Vosser, Milan

Analyst Access June 30, 2026 Richard Vosser & Marjan Daeipour, Frankfurt

Analyst Access July 1, 2026 Richard Vosser, Paris

Corporate Access Jan 11-14, 2027 J P Morgan Global Healthcare Conference, San Francisco

Attendance at all J.P. Morgan Marketing events is strictly by invitation only and is restricted to clients of J.P. Morgan. Please note

this email is not an offer of a meeting or a formal invitation. Access will be subject to meeting availability and company

management approval. Dates may also be subject to change. Please contact your sales representative for further information or

to register your interest.

J. P. Morgan Healthcare Research Links

Elekta AB - CMD feedback: investors likely struggle to underwrite the acceleration to a MSD% mid-term revenue CAGR. note

Vertical SaaS and HealthTech Weekly - News Flow and Valuation as of 06/17/26. note

Concentra Holdings Inc. -Takeaways from Management Meetings. note

REPLAY | Biotech Call Series with Kymera Therapeutics (KYMR) - . note

Vertex Pharmaceuticals - Remain Positive Into 2H. note

Chugai Pharmaceutical (4519) - Key takeaways from briefing on gene therapy for Duchenne muscular dystrophy. note

J.P. Morgan Healthcare Contacts

Marjan Daeipour (EU, Global Sector Head) marjan.daeipour@jpmorgan.com +44 207 134 1329

Elif Korkmaz (US) elif.korkmaz@jpmorgan.com +1 212 622 2949

Healthcare Trading: